R-S-V season is just around the corner, and new research suggests vaccinating adults over 70 could be the best way to use public dollars. Health reporter Katherine Ward has more on why researchers say this is a cost-effective strategy.
Health Matters
RSV vaccines cost-effective in adults 70+
More Videos
-
Health Matters: Dozens sickened after eating BC oysters
-
Health Matters: Nestle launches protein shots in U.S.
-
Health Matters: Canada Post workers seek improved health and safety measures on the job
-
Health Matters: LGBTQ2 advocates try to halt Alberta’s transgender bill
-
Cancer costs a patient $33K, Canadian Cancer Society report says
-
Health Matters: Alberta signs onto federal deal for rare disease drugs
You are viewing an Accelerated Mobile Webpage.
View Original Article